SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $290,000 | -2.0% | 41,725 | 0.0% | 0.00% | – |
Q2 2021 | $296,000 | -65.5% | 41,725 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $859,000 | -2.1% | 41,725 | +16.5% | 0.00% | 0.0% |
Q4 2020 | $877,000 | -1.0% | 35,803 | +14.4% | 0.00% | 0.0% |
Q3 2020 | $886,000 | +418.1% | 31,303 | +106.3% | 0.00% | – |
Q1 2017 | $171,000 | 0.0% | 15,170 | -12.2% | 0.00% | – |
Q4 2016 | $171,000 | -19.3% | 17,270 | 0.0% | 0.00% | – |
Q3 2016 | $212,000 | -77.1% | 17,270 | -45.8% | 0.00% | -100.0% |
Q2 2016 | $926,000 | +8.3% | 31,882 | -0.9% | 0.00% | 0.0% |
Q1 2016 | $855,000 | +63.5% | 32,182 | +116.0% | 0.00% | +100.0% |
Q4 2015 | $523,000 | +16.0% | 14,900 | -2.0% | 0.00% | 0.0% |
Q3 2015 | $451,000 | -25.6% | 15,200 | +4.1% | 0.00% | 0.0% |
Q2 2015 | $606,000 | – | 14,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |